Clinical research - Press Releases

Date	Title	Company
06-Dec-2022	ImaginAb Announces new Clinical Trial at Hull University Teaching Hospitals NHS Trust to Investigate CD8 ImmunoPET in Patients with Renal Cancer and Malignant Melanoma	ImaginAb
06-Dec-2022	Olympus to Join Government Project to Verify Dissemination of Endoscopic AI Diagnosis in Vietnam	OLYMPUS
02-Dec-2022	Eisai presents full results of lecanemab Phase 3 confirmatory Clarity AD study for early Alzheimer’s	Eisai
02-Dec-2022	BioXcel Therapeutics Announces First Patients Dosed in SERENITY III Phase 3 Trial for Acute Treatment of Agitation in Adults with Bipolar I or II Disorder or Schizophrenia	BioXcel Therapeutics
02-Dec-2022	Achilles Therapeutics to Present Early Proof of Concept of Safety and Clinical Activity of Clonal Neoantigen Reactive T Cells at the ESMO Immuno-Oncology Annual Congress 2022	Achilles Therapeutics
02-Dec-2022	Diphtheria outbreak – the Government must drop its complacency and step-up testing, warns expert	Diphtheria outbreak – the Government must drop its complacency and step-up testing, warns expert
01-Dec-2022	International Society of Pharmacometrics Names Pumas-AI Co-Founder Dr. Vijay Ivaturi as President-Elect	Pumas-AI
01-Dec-2022	The Mobile Health/Central Lab Interface, an opportunity for DCT efficiency	mdgroup
29-Nov-2022	Rewind Therapeutics Appoints Dr. Stephen Burbidge to its Management Team	Rewind Therapeutics
24-Nov-2022	Allero Therapeutics Receives EIC Horizon Grant to Advance Treatment of Celiac Disease	Allero Therapeutics
23-Nov-2022	HpVac Appoints Joana Vitte, MD, PhD, as Chief Scientific Officer	HpVac SA
23-Nov-2022	Clinion Achieves GDPR Compliance, continuing its commitment to data privacy and security	Clinion
19-Nov-2022	AJG publishes data from HighTide Therapeutics' Phase 2 study of HTD1801 Treatment in Adults with PSC	HighTide Therapeutics
17-Nov-2022	Grant Avenue Capital Launches Helios Clinical Research	Grant Avenue Capital
17-Nov-2022	Velocity Clinical Research expands to UK	Velocity Clinical Research
16-Nov-2022	Enterome announces presentation of data from ongoing Phase 1/2 trial of its peptide-based immunotherapy EO2401 in recurrent glioblastoma (ROSALIE study) at SNO 2022	Enterome
15-Nov-2022	ADVANCED CLINICAL LAUNCHES REFRESHED BRAND AND WEBSITE	ADVANCED CLINICAL
15-Nov-2022	Eremid® Genomic Services receives CLIA accreditation for its new clinical genomics laboratory	Eremid® Genomic Services
11-Nov-2022	Novotech Chairs BioCentury Summit Workshop on How to Build and Finance an East-West MRCT Strategy	Novotech Health Holdings Pte Ltd
10-Nov-2022	ICR urges continued negotiation after NICE rejection of olaparib for early breast cancer	The Institute of Cancer Research